Free Trial
OTCMKTS:PURE

PURE Bioscience (PURE) Stock Price, News & Analysis

PURE Bioscience logo
$0.08 +0.01 (+10.65%)
As of 09:30 AM Eastern

About PURE Bioscience Stock (OTCMKTS:PURE)

Advanced

Key Stats

Today's Range
$0.08
$0.08
50-Day Range
$0.06
$0.10
52-Week Range
$0.04
$0.14
Volume
300 shs
Average Volume
33,847 shs
Market Capitalization
$10.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PURE Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

PURE MarketRank™: 

PURE Bioscience scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for PURE Bioscience.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of PURE Bioscience is -2.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of PURE Bioscience is -2.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.01% of the float of PURE Bioscience has been sold short.
  • Short Interest Ratio / Days to Cover

    PURE Bioscience has a short interest ratio ("days to cover") of 0.07, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in PURE Bioscience has recently increased by 49.11%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    PURE Bioscience does not currently pay a dividend.

  • Dividend Growth

    PURE Bioscience does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 2 news articles for PURE Bioscience this week, compared to 0 articles on an average week.
  • Search Interest

    5 people have searched for PURE on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, PURE Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    35.56% of the stock of PURE Bioscience is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    PURE Bioscience has minimal institutional ownership at this time.

  • Read more about PURE Bioscience's insider trading history.
Receive PURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PURE Stock News Headlines

Read this warning immediately
Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel
Pure Bioscience Raises $1 Million in Private Placement
PURE Bioscience GAAP EPS of -$0.01, revenue of $0.44M
See More Headlines

PURE Stock Analysis - Frequently Asked Questions

PURE Bioscience's stock was trading at $0.0420 at the start of the year. Since then, PURE stock has increased by 90.5% and is now trading at $0.08.

PURE Bioscience (OTCMKTS:PURE) posted its quarterly earnings data on Monday, March, 16th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm earned $0.44 million during the quarter.

Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PURE Bioscience investors own include Meta Platforms (META), Hydrofarm Holdings Group (HYFM), Twilio (TWLO), NVIDIA (NVDA), Enphase Energy (ENPH) and Novavax (NVAX).

Company Calendar

Last Earnings
3/16/2026
Today
5/26/2026
Fiscal Year End
7/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Chemicals
Current Symbol
OTCMKTS:PURE
CIK
1006028
Employees
10
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.40 million
Net Margins
-108.77%
Pretax Margin
-64.43%
Return on Equity
N/A
Return on Assets
-356.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.25
Quick Ratio
0.18

Sales & Book Value

Annual Sales
$2.20 million
Price / Sales
4.73
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.05) per share
Price / Book
-1.60

Miscellaneous

Outstanding Shares
130,020,000
Free Float
83,784,000
Market Cap
$10.40 million
Optionable
Not Optionable
Beta
0.11

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (OTCMKTS:PURE) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners